Perspective Therapeutics, Inc. (New York Stock Exchange Arca:CATX)
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
Loses money on what it sells.
- Revenue
- $366K
- Net income
- -$116.4M
- Net margin
- -31812.6%
Little or no net debt.
- Total debt
- $4.0M
- Cash
- $48.5M
- Debt / equity
- 0.01
Comfortably covers what is due within a year.
- Current assets
- $241.5M
- Current liabilities
- $36.5M
- Current ratio
- 6.61
Consumes cash and must keep raising it.
- Operating cash flow
- -$93.1M
- Free cash flow
- -$121.2M
- FCF margin
- -33111.2%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 73.8M
- Share growth (1y)
- 4.4%
- Cash runway
- 6 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CATX Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 81.00 K | 76.00 K | 0.00 | 209.00 K | 290.00 K | 369.00 K |
| Revenue Growth (YoY) | -72.07 % | -79.40 % | — | — | -10.77 % | 33.70 % |
| Cost of Revenue | 0.00 | 1.13 M | 0.00 | 775.00 K | 733.00 K | 669.00 K |
| Gross Profit | 81.00 K | -1.05 M | 0.00 | -566.00 K | -443.00 K | -300.00 K |
| SG&A Expense | 7.79 M | 6.99 M | 6.95 M | 7.73 M | 7.71 M | 6.97 M |
| R&D Expense | 21.54 M | 20.25 M | 32.92 M | 20.34 M | 12.17 M | 11.36 M |
| Operating Expenses | 29.34 M | 27.23 M | 39.83 M | 27.30 M | 23.60 M | 18.33 M |
| Operating Income | -29.26 M | -28.28 M | -39.83 M | -27.86 M | -24.04 M | -18.63 M |
| Pretax Income | -26.79 M | -26.19 M | -38.28 M | -25.97 M | -22.00 M | -15.12 M |
| Tax Provision | 196.00 K | 0.00 | -793.00 K | 0.00 | 0.00 | 0.00 |
| Net Income | -26.79 M | -26.19 M | -37.49 M | -25.97 M | -21.48 M | -15.12 M |
| EPS (Basic) | -0.36 | -0.35 | -0.50 | -0.35 | -0.30 | -0.21 |
| EPS (Diluted) | -0.36 | -0.35 | -0.50 | -0.35 | -0.30 | -0.21 |
| Shares Outstanding | 73.81 M | 73.81 M | 74.34 M | 74.30 M | 70.67 M | 70.63 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.